DBV Technologies Reports Positive Data from Milk Allergy Trial Post author:Sam Post published:February 26, 2018 Post category:BioPharma French company DBV Technologies is seeing some positive results from its milk allergy treatment. Source: BioSpace You Might Also Like Dyadic Reports First Quarter 2017 Financial Results May 11, 2017 Bay Area's Calithera Biosciences Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte January 29, 2017 MD Anderson Cancer Center And BridgeBio Launch To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer October 3, 2017
Bay Area's Calithera Biosciences Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte January 29, 2017
MD Anderson Cancer Center And BridgeBio Launch To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer October 3, 2017